Target intelligence / Profile preview

Urinary microbiome (Urobiome)

Target
Urobiome
Molecular classification
Other
01

Overview

The urinary microbiome, or urobiome, refers to the complex community of microorganisms, including bacteria, fungi, and viruses, that inhabit the human urinary tract. Long considered sterile in healthy individuals, advanced sequencing techniques like 16S rRNA sequencing have revealed a diverse resident microbiota that plays a crucial role in maintaining urogenital health [1]. These commensal organisms, particularly species of Lactobacillus, contribute to the host's defense by producing antimicrobial compounds, maintaining an acidic pH, and competing with uropathogens for adhesion sites on the urothelium [2]. Dysbiosis, or an imbalance in this microbial community, is increasingly linked to various urological conditions, including recurrent urinary tract infections (rUTIs), overactive bladder, and interstitial cystitis [3]. Therapeutic strategies targeting the urobiome range from traditional antibiotics to novel approaches like probiotics and microbial ecosystem transplants aimed at restoring a healthy microbial balance [4]. Understanding the urobiome is essential for developing precision medicine approaches for urological diseases and minimizing the systemic impact of broad-spectrum antimicrobial treatments.

Other names
UrobiomeUrinary tract microbiotaUrinary microbiotaBladder microbiome
02

Mechanism of action

Modulation of microbial community composition, competitive exclusion of uropathogens, restoration of commensal bacterial populations, and maintenance of urothelial health through antimicrobial metabolite production.

03

Biological functions

Immune response modulationPathogen competitionUrothelial barrier maintenanceMetabolic activityOther
04

Disease associations

InfectionUrinary tract infectionOveractive bladderInterstitial cystitisBladder cancerUrolithiasisOther
05

Safety considerations

Antibiotic-induced dysbiosisDevelopment of antimicrobial resistance (AMR)Risk of opportunistic infectionsInconsistent efficacy of probiotic strainsPotential for systemic translocation of bacteria
06

Interacting drugs

Nitrofurantoin

5 more in the full profile.

07

Biomarkers

16S rRNA gene sequencingAlpha diversity indices (e.g., Shannon index)Lactobacillus-to-Enterobacteriaceae ratioMetagenomic profilingExpanded Quantitative Urine Culture (EQUC)

Beyond the preview

Go deeper on Urinary microbiome (Urobiome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urinary microbiome (Urobiome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call